AVE 0.00% 0.3¢ avecho biotechnology limited

Oscar, I disagree with your second paragraph regarding...

  1. 10,009 Posts.
    Oscar, I disagree with your second paragraph regarding "dilutingh their resources". If Newjos post is accurate they are concentrating by proving their technology across 42 differant drugs. They probably won;t take any drugs to market on the own.

    Their strategy is to license or co-develop all their products. The technology has such a broad range of applications it would be well beyond their ability to maximise its potential alone.

    PoS.

 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
0.000(0.00%)
Mkt cap ! $9.507M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
64 103305097 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 22478912 7
View Market Depth
Last trade - 09.59am 05/07/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.